Description

2(1H)-Quinoxalinone,3,4-Dihydro-4-[[[2-(1-Methylethyl)-4-Quinazolinyl]Thio]Acetyl]-(9Ci) is a sophisticated heterocyclic organic compound that serves as a critical advanced pharmaceutical intermediate and a valuable scaffold in medicinal chemistry research. Its unique molecular architecture, featuring fused quinoxalinone and quinazoline rings linked via a thioacetyl bridge, makes it a versatile building block for the synthesis of novel bioactive molecules. This compound is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new therapeutic agents, particularly in areas requiring complex heterocyclic frameworks.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of potential drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Kinase Inhibitor Development: Building block for creating novel compounds that modulate kinase activity, relevant in oncology and inflammatory diseases.
• Chemical Biology Probes: Used to develop molecular probes for studying biological processes and target validation.
• Organic Synthesis: Versatile intermediate for constructing complex polyheterocyclic systems in academic and industrial research.
• Contract Research & Manufacturing (CRAM): Supplied to organizations offering custom synthesis and process development services.

Basic Information

Product Name	2(1H)-Quinoxalinone,3,4-Dihydro-4-[[[2-(1-Methylethyl)-4-Quinazolinyl]Thio]Acetyl]-(9Ci)
CAS No.	604794-75-4
Molecular Formula	C21H20N4O2S
Molecular Weight	392.48 g/mol
Synonyms	4-[[[2-(1-Methylethyl)-4-quinazolinyl]thio]acetyl]-3,4-dihydro-2(1H)-quinoxalinone; 4-[[[2-Isopropyl-4-quinazolinyl]thio]acetyl]-3,4-dihydro-2(1H)-quinoxalinone; 3,4-Dihydro-4-[[[2-(1-methylethyl)-4-quinazolinyl]thio]acetyl]-2(1H)-quinoxalinone; 4-[(2-Isopropylquinazolin-4-yl)sulfanylacetyl]-1,4-dihydroquinoxalin-2-one; 604794-75-4; Quinoxalinone derivative; Isopropylquinazolinyl thioacetyl quinoxalinone
EINECS	Contact for details

Quality Control

Our production of 2(1H)-Quinoxalinone,3,4-Dihydro-4-[[[2-(1-Methylethyl)-4-Quinazolinyl]Thio]Acetyl]-(9Ci) adheres to stringent quality protocols suitable for research and pharmaceutical intermediate applications. Each batch undergoes comprehensive analytical characterization using techniques including HPLC, NMR, and mass spectrometry to ensure structural identity and purity. We provide detailed Certificates of Analysis (COA) with every shipment, documenting critical quality attributes. Our quality management system supports the traceability and consistency required for cGMP-compliant supply chains.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect the compound from moisture. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.